科研速递论坛

标题: Tivozanib Versus Sorafenib As Initial Targeted [打印本页]

作者: 初学者 时间: 2013-10-14 11:45
标题: Tivozanib Versus Sorafenib As Initial Targeted

题名	Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
作者	Robert J. Motzer
杂志	JCO September 9, 2013
链接	http://jco.ascopubs.org/content/early/2013/09/09/JCO.2012.47.4940.abstract

作者: berkeley 时间: 2013-10-14 11:45
链接:http://pan.baidu.com/s/15RfON 密码:5gfb

作者: berkeley 时间: 2013-10-14 11:46
1111111111111

欢迎光临科研速递论坛 (http://www.expaper.cn/)